The Davidson Lab uses high throughput sequencing technologies and computational approaches to study the dynamics of infectious diseases. We are particularly focused on Mycobacteria species and other bacteria affecting Cystic Fibrosis (CF) and non-CF patients. Research areas include the genetic epidemiology of pathogen populations, pathogen genome evolution, and microbial responses during disease progression and antibiotic treatment. Current projects range from using functional genomics to identify genetic underpinnings of virulence and antibiotic resistance to developing molecular diagnostics for rapid detection of bacteria in clinical samples. The overarching goals are to improve the diagnosis and treatment of patients with infectious diseases.
Lab Resources & Services
Our group is located on the 6th floor of the Smith Building. We work closely with the CGEH Genomics Facility and have access to a high performance computing cluster in the Center for Genes, Environment and Health for large scale data analyses.
- Rebecca Davidson, PhD
- Sara Kammlade, MS, Bioinformatics Analyst I
- Jeanne Benoit, PhD, Bioinformatics Analyst II
Dr. Rebecca Davidson
National Jewish Health
Center for Genes, Environment and Health
Smith Building, Room A636
1400 Jackson Street
Denver, CO 80206
Davidson RM, Epperson LE. Microbiome Sequencing Methods for Studying Human Diseases. Methods in Molecular Biology (Clifton, N.J.). 2018; 1706:77-90. Abstract
Martiniano SL, Davidson RM, Nick JA. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Pediatric Pulmonology. 2017; 52(S48):S29-S36. Abstract